Bridging from Clinical Development to Commercialization: Supporting Patients

Strategies to successfully transition Phase III clinical trial patients to commercial products, while ensuring affordability, accessibility, and compliance with international reporting regulations.

Date: November 19, 2024 

Time: 10:00-11:00AM US EST / 4:00-5:00 PM CEST

Register Now

About the Webinar

Are you a pharmaceutical or biotech manufacturer preparing to commercialize a drug and wondering how to support your Phase III clinical trial patients post approval? In today’s complex access and reimbursement landscape, preparing your patients for the transition from clinical trial to commercial product requires proactive planning and collaboration with multiple stakeholders. While managing patient access and affordability during this transition is achievable, it is essential to understand the necessary support systems and comply with the reporting regulations in various countries.

With years of experience supporting product launches in retail, specialty, and rare disease products, we will guide you through the crucial components every manufacturer must have to support trial patients transitioning to the commercial space. You will gain valuable insights into the key requirements, critical components, and how to effectively implement these strategies for success.

What You Will Learn

  • Key considerations for successfully moving patients into commercial space.
  • Best practices for building programs to support patients in their journey.
  • Insights into measuring the success of these programs.

Who Should Attend?

This webinar is ideal for:

  • Managers and leaders who are responsible for marketing, patient access and reimbursement, and safety reporting.
  • Professionals working in operations, research and development, patient access, and medical information.

Unable to join? Register and you will receive the recording after the live session.

Meet the Speakers

  • Stephanie Pruett Bio Photo

    Stephanie Pruett

    Associate Director, Medical Information

    View Bio

Stephanie Pruett

With 9 years of experience in the pharmaceutical industry, Stephanie specializes in Medical Information strategy, cross-functional collaboration, and process optimization. Currently serving as an Associate Director, Medical Information at ProPharma, she leads a diverse team of pharmacists, nurses, and life science professionals, providing expert Medical Information support to pharmaceutical clients. Stephanie is known for her meticulous attention to detail and strong project management capabilities, consistently ensuring smooth communication and high-quality project execution.

Driven by a passion for innovation, Stephanie is eager to contribute to the development of cutting-edge Medical Information solutions, ensuring optimal support for healthcare professionals and patients alike. Stephanie has a strong background in developing patient-centric solutions that ensure patients have access to accurate, timely information, empowering them to make informed decisions about their care. Stephanie’s dedication to advancing healthcare outcomes and fostering innovation reflects her commitment to delivering impactful results within the pharmaceutical industry.